Breast Cancer Coverage from Every Angle

Rita Nanda, MD, on Treating Triple-Negative Breast Cancer: An Expert Perspective

Posted: Wednesday, April 21, 2021

Rita Nanda, MD, of the University of Chicago, talks about the challenges facing clinicians who treat patients with triple-negative breast cancer, research on immunotherapy in combination with chemotherapy, and the high response rates in first-line therapy for those with advanced-stage disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.